DNAPrint Genomics, Inc. Announces Relocation and Expansion
SARASOTA, Fla., Sep 25, 2000 (BUSINESS WIRE) -- DNAPrint genomics, Inc., (Pink
Sheets:DNAP), a Sarasota based genomics company, announced today that it is
relocating its laboratory and offices to 900 Coconut Ave., Sarasota, FL. The
Company has reached agreement for a multi-year commitment with the owner of this
property that will guarantee the company occupancy through 2010. The new
location sits on the Northwest end of the downtown Sarasota business district
where major commercial development is expanding the gentrification of the
downtown area. The Company will be specifically located across the street from
the new Renaissance development, which includes a new $100 million Ritz-Carlton
luxury hotel.
The new laboratory will provide adequate space for growth and acquisition, and
accommodate new state-of-the-art equipment that is scheduled for delivery in the
immediate future.
To celebrate the expansion and relocation, the Company will be hosting an Open
House on December 2, 2000 from 12 Noon to 6:00 p.m. The Company will be sending
formal invitations to its investors and shareholders, and will also invite the
premier Brokerage Houses, Investment Banking Firms and Money Managers who have
expressed their interest in the Company.
In addition to a scheduled touring of the new facility, Dr. Tony Frudakis will
give a presentation detailing the Genomics industry and the Company's strategic
plan. Dr. Frudakis will field questions specific to the science and business
model of the Company after the presentation.
About DNAPrint genomics
DNAPrint genomics, Inc. is developing complex genetic analytics and knowledge
resources for next generations personalized medicine. The company provides
practitioners of genomic research and personalized medicine with a comprehensive
system for complex trait dissection and patient classification. DNAPrint
genomics Inc. was founded by a group of scientists with research and commercial
experience in high-level mathematical modeling, programming and molecular
genetics. For more information about the company, please visit www.dnaprint.com.
For scientific inquiries please contact: Dr. Tony Frudakis at 941/351-4543. All
other inquiries please contact: Richard Craig Hall at 941/341-0136.
Except for factual statements made herein, the information contained in this
press release consists of forward-looking statements that involve risks and
uncertainties. The Company's actual results could differ materially from those
contained in such statements. Factors that could cause or contribute to such
differences include unexpected shortages of critical components, rescheduling or
cancellation of customer orders, the timing and market acceptance of new product
introductions by the Company and its competitors, and general competition and
price pressures in the marketplace.
CONTACT: DNAPrint genomics Inc., Sarasota
Scientific Inquiries:
Dr. Tony Frudakis, 941/351-4543
or
All other inquiries please contact:
Richard Craig Hall, 941/341-0136 |
